DBV Technologies S.A. financial data

Symbol
DBVT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
107 Avenue De La Republique, Chatillon, France
State of incorporation
France
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 358 % -43%
Debt-to-equity 39.3 % +30.6%
Return On Equity -106 % -79.4%
Return On Assets -76.2 % -67.6%
Operating Margin -836 % +54.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.5M shares +0.22%
Entity Public Float 183M USD -43.4%
Common Stock, Value, Issued 11M USD +0.24%
Weighted Average Number of Shares Outstanding, Basic 96.2M shares +0.13%
Weighted Average Number of Shares Outstanding, Diluted 96.2M shares +0.13%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 12.5M USD +126%
Research and Development Expense 83.2M USD +7.99%
Selling and Marketing Expense 3.09M USD +97.8%
General and Administrative Expense 30.9M USD +4.78%
Operating Income (Loss) -105M USD -2.07%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -102M USD -1.25%
Income Tax Expense (Benefit) 42K USD
Net Income (Loss) Attributable to Parent -102M USD -1.3%
Earnings Per Share, Basic -1.05 USD/shares +0.94%
Earnings Per Share, Diluted -1.05 USD/shares +0.94%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46.4M USD -68.9%
Other Assets, Current 22.3M USD +10.8%
Assets, Current 68.8M USD -59.4%
Property, Plant and Equipment, Net 13M USD -0.84%
Operating Lease, Right-of-Use Asset 5.99M USD +331%
Intangible Assets, Net (Excluding Goodwill) 43K USD -29.5%
Other Assets, Noncurrent 5.28M USD -11.6%
Assets 93.1M USD -51%
Liabilities, Current 30.9M USD -1.69%
Operating Lease, Liability, Noncurrent 7.04M USD +7387%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 39M USD -14.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 709K USD -6.83%
Retained Earnings (Accumulated Deficit) -263M USD -15.7%
Stockholders' Equity Attributable to Parent 54M USD -62.5%
Liabilities and Equity 93.1M USD -51%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -34.7M USD -66.5%
Net Cash Provided by (Used in) Financing Activities -62K USD -343%
Net Cash Provided by (Used in) Investing Activities -2.13M USD -5176%
Common Stock, Shares Authorized 96.5M shares
Common Stock, Shares, Issued 96.5M shares
Common Stock, Par or Stated Value Per Share 0.1 EUR/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -39.8M USD -136%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 46.4M USD -68.9%
Deferred Tax Assets, Valuation Allowance 310M USD +10.3%
Deferred Tax Assets, Gross 310M USD +10.3%
Operating Lease, Liability 7.41M USD +359%
Payments to Acquire Property, Plant, and Equipment 1.34M USD +1103%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -96.1M USD -18.6%
Lessee, Operating Lease, Liability, to be Paid 9.08M USD +406%
Property, Plant and Equipment, Gross 31.6M USD +5.67%
Operating Lease, Liability, Current 374K USD -75.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.3M USD +925%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.49M USD -10.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.66M USD +845%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 307M USD +12.2%
Operating Lease, Payments 501K USD +1.01%
Additional Paid in Capital 316M USD -16%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 1.59M USD +17.5%